子供と青少年における心理的多用薬および関連因子
Mutlu Muhammed Özbek1, Ekin Atay2, Doğa Sevinçok3
1Department of Child and Adolescent Psychiatry, Yalova University, Faculty of Medicine, Yalova, Türkiye.
Psychiatry investigation
|August 21, 2025
まとめ
行動障害,高齢,併発性診断の児童および青少年精神科の患者は,ポリファーマシーを受ける可能性が高い. これらの要因を理解することは 薬の使用を減らすための鍵です
科学分野:
- 児童・青少年精神科
- 臨床心理学
- 精神薬学
背景:
- 多剤薬は子供や青年の精神医学で一般的ですが,その使用に影響を与える要因については,さらなる調査が必要です.
- 多剤療法に関連する臨床的特徴を理解することは,治療戦略を最適化するために極めて重要です.
研究 の 目的:
- 児童・青少年精神科の外科医診療所における患者の臨床的特徴を調べる.
- 臨床サンプルにおける多薬症とその関連因子の有病率を決定する.
主な方法:
- 569人の患者の完全なデータを遡及的に分析した.
- DSM-5の基準に基づく精神疾患の診断
- 収集されたデータには,年齢,性別,教育,精神病診断,治療が含まれています.
主要な成果:
- 多剤薬局の利用者では過敏がより一般的であり,多剤薬局以外の利用者では家庭の問題がより一般的であった.
- 行動障害の診断,高齢化,精神疾患の併発性は,ポリファーマシーと有意に関連していた.
- 行動障害 (OR=11. 08),年齢 (OR=1.14) および併発性 (OR=116. 87) が強く予測されたポリファーマシー.
結論:
- 行動障害,年齢,併発性精神疾患の診断は,小児精神病患者のポリファーマシーのリスクを大幅に高めます.
- ポリファーマシーに寄与する要因を特定することは,この集団における不必要な薬を最小限に抑えるために不可欠です.
関連する概念動画
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
296
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
296
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
947
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
947


